A woman from Kent has become the first cystic fibrosis sufferer in the UK to undergo experimental stem cell treatment for the genetic condition which affects one in 2,500 people. Roisin Kelleher O'Callaghan from Faversham was told her only hope of survival lay in a double lung transplant -- but the new stem cell therapy offers a potential alternative. Here's our report from Ian Palmer. | BBC Kent

The UK medicines regulator, the MHRA, has today approved the once-a-day triple therapy, Alyftrek (vanza triple). 💬 The next stage of the process is the ongoing assessment by the National Institute for Health and Care Excellence (NICE) who will make a decision on whether it should be made available on the NHS. Find out more on our website. ➡️ https://ow.ly/Rnhh50VbJ2z #cysticfibrosis #cftrust #Alyftrek #cysticfibrosistrust #cflife | Cystic Fibrosis Trust